Eclipse, a venture capital firm investing in the digital transformation of the world’s physical industries, and Mayo Clinic have established and seeded funding for Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new therapies.
“Yesterday, I went to sleep as acting NCI director, and this morning, as I woke up, I have a new boss, Monica Bertagnolli,” Douglas R. Lowy said in the morning of Oct. 3, addressing a well-caffeinated meeting of the Association of American Cancer Institutes.
Patient navigation didn’t start out as a business idea. The concept—and the adaptation of the nautical term—are attributed to the surgeon Harold Freeman, when he started to practice in Harlem after finishing his residency at Memorial Sloan Kettering Cancer Center in 1968. “If people meet barriers in getting through the healthcare system with cancer and... […]
Elizabeth Jaffee, Electra Paskett, and Pelatonia received the 2022 American Association of Cancer Institutes awards.
William A. Calo was named co-leader of the Cancer Control Program of the Penn State Cancer Institute.
The Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital, and Texas Children’s Hospital was awarded more than $10.3 million by NCI to continue translational lymphoma research.
Dina M. Jones, assistant professor for the University of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health’s Center for the Study of Tobacco, received a $733,000 K01 grant to conduct a study that seeks to understand disparities in smoking cessation among African American menthol cigarette smokers.
The Jack Martin Fund has built on its partnership with the Mount Sinai Health System to provide care and support to children with cancer through a $3.5 million gift to The Mount Sinai Hospital to establish the Jack Martin Fund Child and Adolescent Imaging Center at Mount Sinai Kravis Children’s Hospital.
Neil Palmisiano was named the new deputy director of phase I therapeutics for hematologic malignancies and co-medical director of the Office of Human Research Services at Rutgers Cancer Institute; and new system leader for Leukemia for RWJBarnabas Health.
Joseph R. Triggs has been named assistant professor in the Division of Gastroenterology of the Department of Medicine at Fox Chase Cancer Center.
